A recent meta-analysis study in Head and Neck Squamous Carcinoma (HNSCC) identified that NSUN2 had approximately 2-fold upregulation in tumors, which was associated with 22 months shorter overall survival and a higher mortality risk [118]. Here, NSUN2 is linked to head and neck squamous cell carcinoma.